Martin Jacko

Company: Aperture Therapeutics

Job title: Chief Executive Officer

Seminars:

Discovery of Protective Genetic Variants to Develop Disease Modifying Therapeutics for ALS 2:30 pm

Unpacking the role of genetic heterogeneity in ALS  Shifting perspective – protective genetic variants in nonneuronal genes that impact disease progression and survival Development of targeted disease modifying therapeuticsRead more

day: Conference Day One Track A PM